0.1 mM PMSF, and 25% glycerol.
Molecular mass: ∼82 kDa
Purity: 70–95% (SDS-PAGE, see Figure 1)
Specific Activity: 53–71 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product
for mPAA treated feed: 92% vs 71% reduction, Figure 6),
however, HuMAb recovery showed a lower impact for Millistak+® HC
X0HC filters (for pDADMAC treated feed: 84% vs 71% recovery and
for mPAA treated
USP chapter �1223� (6)
using the MPN table from the FDA Bacteriological
Analytical Manual, Appendix 2 (23). The three
highest dilutions of the microbial solution were used
211Vol. 71, No. 3, May–June 2017
Resistance Patterns in a Campylobacter Population Isolated from Poultry Farms in Switzerland. AEM. 71(6):2840-
2847. https://doi.org/10.1128/aem.71.6.2840-2847.2005
7. Wittwer M, Keller J, Wassenaar
USP chapter �1223� (6)
using the MPN table from the FDA Bacteriological
Analytical Manual, Appendix 2 (23). The three
highest dilutions of the microbial solution were used
211Vol. 71, No. 3, May–June 2017
McKinney, M. et al., J. Immunol. Methods, 96,
271 (1987).
2. Bird, P. et al., J. Immunol. Methods, 71,
97 (1984).
3. Tousch, D. et al., BioChromatography, 5,
30 (1990).
4. Haaijman
a family of integrin
inhibitory proteins from viper venoms., Proc. Soc.
Exp. Biol. Med., 195, 168-71 (1990).
3. Gan, Z.R., et al., Echistatin. A potent platelet
aggregation inhibitor from the venom
Nature, 405, 421-424 (2000).
5. Qin, C., et al., Cancer Res., 63, 958-964 (2003).
6. Yoshizawa, K., et al., Cancer, 95, 2243-2251 (2002).
HO
CH3
H3C
CH3
O
CH3
O
NH
S
O
OTroglitazone
mM glutathione, 0.1 mM EDTA,
0.25 mM DTT, 0.1 mM PMSF, 25% glycerol.
Molecular mass: ∼71 kDa
Purity: 70–95% (SDS-PAGE, see Figure 1)
Specific Activity: 457–619 nmole/min/mg (see Figure 2)
Precautions
Nature, 405, 421-424 (2000).
5. Qin, C., et al., Cancer Res., 63, 958-964 (2003).
6. Yoshizawa, K., et al., Cancer, 95, 2243-2251 (2002).
HO
CH3
H3C
CH3
O
CH3
O
NH
S
O
OTroglitazone
glycerol.
Molecular mass: ∼90 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 71–95 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not for
chymotrypsinogen
secondary structure and aggregation during
freezing, drying, and rehydration. Biophys. J.,
71(4), 2022-2032 (1996).
GCY/RXR 8/03
Sigma brand products are sold through Sigma-Aldrich
Neat 24 24 100
1:2 11 12 94
1:4 6 6 100
1:8 3.8 3 127
Specificity
• The specificity of this assay for Phospho-ATF
phosphorylated on threonine 69 and 71 was
confirmed by peptide
Gospodarowicz, D., and Moran, J., J. Proc. Natl.
Acad. Sci. USA, 71, 4648 (1974).
2. Gospodarowicz, D. et al., Endocrine Rev., 8, 95
(1987).
3. Gospodarowicz, D., and Cheng, J., J. Cell Physiol.
Nature, 363(6427), 368-71 (1993).
2. Walworth, NC. et al., Rad-dependent response of
the CHK1-encoded protein kinase at the DNA
damage checkpoint. Science, 271(5247), 353-6
(1996).
PRECISIO is
Nature, 363(6427), 368-71 (1993).
2. Walworth, NC. et al., Rad-dependent response of
the CHK1-encoded protein kinase at the DNA
damage checkpoint. Science, 271(5247), 353-6
(1996).
JR,MAM 12/08
Nature, 363(6427), 368-71 (1993).
2. Walworth, NC. et al., Rad-dependent response of
the CHK1-encoded protein kinase at the DNA
damage checkpoint. Science, 271(5247), 353-6
(1996).
PRECISIO is
Nature, 363(6427), 368-71 (1993).
2. Walworth, NC. et al., Rad-dependent response of
the CHK1-encoded protein kinase at the DNA
damage checkpoint. Science, 271(5247), 353-6
(1996).
PRECISIO is
Nature, 363(6427), 368-71 (1993).
2. Walworth, NC. et al., Rad-dependent response of
the CHK1-encoded protein kinase at the DNA
damage checkpoint. Science, 271(5247), 353-6
(1996).
PRECISIO is